CH554892A - Verfahren zur herstellung von 1,5-substituierten oder 1,6substituierten benzimidazolen. - Google Patents

Verfahren zur herstellung von 1,5-substituierten oder 1,6substituierten benzimidazolen.

Info

Publication number
CH554892A
CH554892A CH315871A CH315871A CH554892A CH 554892 A CH554892 A CH 554892A CH 315871 A CH315871 A CH 315871A CH 315871 A CH315871 A CH 315871A CH 554892 A CH554892 A CH 554892A
Authority
CH
Switzerland
Prior art keywords
substituted
preparation
benzimidazoles
substituted benzimidazoles
Prior art date
Application number
CH315871A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH554892A publication Critical patent/CH554892A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH315871A 1970-03-05 1971-03-04 Verfahren zur herstellung von 1,5-substituierten oder 1,6substituierten benzimidazolen. CH554892A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1695670A 1970-03-05 1970-03-05
US088493A US3873558A (en) 1970-03-05 1970-11-10 Process for preparing 1,5-substituted or 1,6-substituted benzimidazoles

Publications (1)

Publication Number Publication Date
CH554892A true CH554892A (de) 1974-10-15

Family

ID=26689268

Family Applications (1)

Application Number Title Priority Date Filing Date
CH315871A CH554892A (de) 1970-03-05 1971-03-04 Verfahren zur herstellung von 1,5-substituierten oder 1,6substituierten benzimidazolen.

Country Status (3)

Country Link
US (1) US3873558A (de)
CA (1) CA939356A (de)
CH (1) CH554892A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1558341A2 (de) * 2002-11-01 2005-08-03 Paratek Pharmaceuticals, Inc. Transkriptionsfaktor modulierendeverbindungen und ihre verwendung

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344927A (en) * 1989-02-02 1994-09-06 Yamanouchi Pharmaceutical Co., Ltd. Tetrahydrobenzimidazole derivatives and pharmaceutical compositions containing same
US20030009034A1 (en) * 2001-03-22 2003-01-09 Neil Wishart Transition metal mediated process
US20030109714A1 (en) * 2001-03-22 2003-06-12 Neil Wishart Transition metal mediated process
US7405235B2 (en) * 2001-05-04 2008-07-29 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
CA2562763A1 (en) 2004-04-23 2006-07-20 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
WO2008130368A2 (en) * 2006-06-23 2008-10-30 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
WO2009005551A2 (en) * 2007-03-27 2009-01-08 Paratek Pharmaceuticals, Inc. Transcription factor modulating compounds and methods of use thereof
US20110059962A1 (en) * 2009-04-22 2011-03-10 Alekshun Michael N Transcription factor modulating compounds and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236855A (en) * 1964-01-17 1966-02-22 Merck & Co Inc Certain n-phenyl(thiazole-hydroxamidine) compounds and their preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1558341A2 (de) * 2002-11-01 2005-08-03 Paratek Pharmaceuticals, Inc. Transkriptionsfaktor modulierendeverbindungen und ihre verwendung
EP1558341A4 (de) * 2002-11-01 2010-09-08 Paratek Pharm Innc Transkriptionsfaktor modulierendeverbindungen und ihre verwendung

Also Published As

Publication number Publication date
CA939356A (en) 1974-01-01
US3873558A (en) 1975-03-25

Similar Documents

Publication Publication Date Title
CH552595A (de) Verfahren zur herstellung von n-(1,1,1-trisubstituierten)methylazolen.
CH546241A (de) Verfahren zur herstellung von 6,7-benzomorphanen.
CH551979A (de) Verfahren zur herstellung von 1,2-dihydropyrimidinen.
CH580082A5 (de) Verfahren zur herstellung von 2,4-diamino-5-benzylpyrimidinen.
CH547787A (de) Verfahren zur herstellung von virustatischen, in 4-stellung substituierten 1-acylthiosemicarbaziden.
CH554892A (de) Verfahren zur herstellung von 1,5-substituierten oder 1,6substituierten benzimidazolen.
CH554858A (de) Verfahren zur herstellung von methyl-n-acetal-6,7-aziridino-6-desamino-7-desoxy-(alpha)-thiolincosamidinen.
CH555844A (de) Verfahren zur herstellung von 1-aza-5-hydroxymethyl-3, 7-dioxablicyclo-(3,3,0)-octanderivaten.
CH556855A (de) Verfahren zur herstellung von substituierten 1,2-dihydro1,3,5-triazinen.
CH556352A (de) Verfahren zur herstellung von 2-acylamino-1,3,4-thiadiazol-(thi)onen-(5).
CH549581A (de) Verfahren zur herstellung von 4-amino-6,7,8-trialkoxychinazolinen.
CH553758A (de) Verfahren zur herstellung von azidosulfonylcarbanilaten.
CH555806A (de) Verfahren zur herstellung von derivaten der 2,6-diaminobenzoesaeure.
CH550786A (de) Verfahren zur herstellung von 2,9-dioxatricyclo (4,3,1,0 3,7) decanonen.
CH557365A (de) Verfahren zur herstellung von 5-amino-substituierten imidazolen.
CH558802A (de) Verfahren zur herstellung von imidazolen.
CH534662A (de) Verfahren zur Herstellung von alkylierten N,N'-Diphenyloxamiden
AT305963B (de) Verfahren zur Herstellung von N,O-Dialkylhydroxylaminen
CH548966A (de) Verfahren zur herstellung von 1,2-cycloalkyliden-3,5,6tri-o-benzyl-d-glucofuranosen.
CH546730A (de) Verfahren zur herstellung von n,n'-bis-trifluormethyl-tetrafluoraethylendiamin.
CH557825A (de) Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen.
CH547796A (de) Verfahren zur herstellung von 1,3-dioxolanen und -dioxanen.
CH557801A (de) Verfahren zur herstellung von 1,1,3-trialkoxy-2-cyanopropanen.
CH557371A (de) Verfahren zur herstellung von substituierten 5-hydroxyoenanthsaeurelactonen.
CH558358A (de) Verfahren zur herstellung von n-vinylchinolonen.

Legal Events

Date Code Title Description
PL Patent ceased